Aspira Pathlab & Diagnostics Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported sales was INR 38.18 million compared to INR 34.08 million a year ago. Revenue was INR 38.94 million compared to INR 34.81 million a year ago. Net loss was INR 5.03 million compared to INR 2.59 million a year ago. Basic loss per share from continuing operations was INR 0.49 compared to INR 0.25 a year ago. Diluted loss per share from continuing operations was INR 0.49 compared to INR 0.25 a year ago.

For the full year, the company reported sales was INR 132.05 million compared to INR 144.57 million a year ago. Revenue was INR 136.26 million compared to INR 147.78 million a year ago. Net loss was INR 26.72 million compared to INR 0.887 million a year ago. Basic loss per share from continuing operations was INR 2.6 compared to INR 0.09 a year ago. Diluted loss per share from continuing operations was INR 2.6 compared to INR 0.09 a year ago.